Pyruvate kinase M2 (PKM2) is not only a vital enzyme in regulating cancer glycolysis, but is also a transcription that regulates gene expression through nuclear translocation, so the targeting PKM2 can be a promising therapy for prostate cancer. This evidence concerns the gene PKM and prostate carcinoma.